Barclays Reiterates €25.50 Price Target for Vivendi (VIV)

Share on StockTwits

Vivendi (EPA:VIV) has been assigned a €25.50 ($29.65) price target by investment analysts at Barclays in a report released on Tuesday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock.

A number of other equities research analysts have also weighed in on the stock. Deutsche Bank set a €34.00 ($39.53) price objective on shares of Vivendi and gave the company a “buy” rating in a report on Friday, April 5th. HSBC set a €26.50 ($30.81) price objective on shares of Vivendi and gave the company a “buy” rating in a report on Wednesday, February 20th. Credit Suisse Group set a €24.50 ($28.49) price objective on shares of Vivendi and gave the company a “buy” rating in a report on Tuesday, January 15th. Jefferies Financial Group set a €22.00 ($25.58) price objective on shares of Vivendi and gave the company a “neutral” rating in a report on Monday, January 14th. Finally, UBS Group set a €25.00 ($29.07) price objective on shares of Vivendi and gave the company a “buy” rating in a report on Thursday, February 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of €26.58 ($30.91).

Vivendi has a twelve month low of €16.85 ($19.59) and a twelve month high of €24.87 ($28.92).

Vivendi Company Profile

Vivendi SA operates as a content media and communication company in France, rest of Europe, the Americas, Asia/Oceania, and Africa. It operates through Universal Music Group, Canal+ Group, Havas, Gameloft, Vivendi Village, and New Initiatives segments. The Universal Music Group segment engages in the sale of digital and physical recorded music; and exploitation of music publishing rights, as well as provision of artist and merchandising services.

See Also: Bear Market

Analyst Recommendations for Vivendi (EPA:VIV)

Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.